FBSA-based therapeutic and radioimaging conjugates targeting carbonic anhydrase positive cancers
US11524082B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2018 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | Jan 6, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2090/3941
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions and methods of carbonic anhydrase IX inhibitors. The present disclosure also relates to targeting conjugates of carbonic anhydrase IX inhibitors. The present disclosure also relates to the use of targeting conjugates of carbonic anhydrase IX inhibitors in methods of treating disease and for imaging of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.